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ABSTRACT
Deafferentation of the auditory nerve from loss of sensory cells is associated with
degeneration of nerve fibers and spiral ganglion neurons (SGN). SGN survival following
deafferentation can be enhanced by application of neurotrophic factors (NTF), and NTF can
induce the regrowth of SGN peripheral processes. Cochlear prostheses could provide targets
for regrowth of afferent peripheral processes, enhancing neural integration of the implant,
decreasing stimulation thresholds, and increasing specificity of stimulation. The present
study analyzed distribution of afferent and efferent nerve fibers following deafness in guinea
pigs using specific markers (parvalbumin for afferents, synaptophysin for efferent fibers) and
the effect of brain derived neurotrophic factor (BDNF) in combination with acidic fibroblast
growth factor (aFGF). Immediate treatment following deafness was compared with 3-week-
delayed NTF treatment. Histology of the cochlea with immunohistochemical techniques
allowed quantitative analysis of neuron and axonal changes. Effects of NTF were assessed at
the light and electron microscopic levels. Chronic BDNF/aFGF resulted in a significantly
increased number of afferent peripheral processes in both immediate- and delayed-treatment
groups. Outgrowth of afferent nerve fibers into the scala tympani were observed, and SGN
densities were found to be higher than in normal hearing animals. These new SGN might
have developed from endogenous progenitor/stem cells, recently reported in human and
mouse cochlea, under these experimental conditions of deafferentation-induced stress and
NTF treatment. NTF treatment provided no enhanced maintenance of efferent fibers, al-
though some synaptophysin-positive fibers were detected at atypical sites, suggesting some
sprouting of efferent fibers. J. Comp. Neurol. 507:1602–1621, 2008. © 2008 Wiley-Liss, Inc.
Indexing terms: cochlea; nerve fiber regeneration; brain-derived neurotrophic factor; acidic
fibroblast growth factor
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Deafferentation of the auditory nerve from loss of sen-
sory cells (inner hair cells; IHC) is associated with the loss
of auditory function. As IHC are damaged, they release
excess glutamate, resulting in the swelling and bursting of
the peripheral processes of the auditory nerve that had
been connected to the IHC. These auditory nerve pro-
cesses are capable of recovery and reconnecting if IHC
recover (Puel et al., 1995, 1998); in the presence of massive
IHC loss, however, these processes do not recover. The
unmyelinated portion of the auditory nerve peripheral
processes rapidly regresses to the habenula perforata, fol-
lowed by a slower regression of myelinated portion toward
the cell bodies of the auditory nerve [spiral ganglion neu-
rons (SGN); Webster and Webster, 1981; Koitchev et al.,
1982; Bichler et al., 1983; Spoendlin, 1984; Morest et al.,
1998]. As with deafferentation-associated cell death in
other systems, SGN apoptosis appears to be induced by
the loss of survival factors, including neurotrophic factors,
following IHC destruction (for reviews see Miller et al.,
2002; Roehm and Hansen, 2005). Apoptosis of SGN
(Roehm and Hansen, 2005) proceeds gradually over a pe-
riod of time, with the rate of cell death occurring more
rapidly in rat, mouse, chinchilla, or guinea pig (Webster
and Webster, 1981; Koitchev et al., 1982; Bichler et al.,
1983; Jyung et al., 1989; McFadden et al., 2004), compared
with cat (Leake and Hradek, 1988) and primate, including
man (Suzuka and Schuknecht, 1988; Nadol et al., 1989;
Nadol, 1990, 1997; Zimmermann et al., 1995; Incesulu and
Nadol, 1998). In the guinea pig, there is a large SGN loss
by 2 months following hair cell loss (Webster and Webster,
1981; Jyung et al., 1989).
The loss of SGN can have serious clinical repercussions.
Cochlear prostheses are now used to restore hearing suc-
cessfully following deafness from sensory cell loss in large
numbers of patients. Cochlear prostheses, however, de-
pend on direct electrical stimulation of the auditory nerve
neurons for their function, and loss of SGN can compro-
mise their efficacy. Studies have now shown that SGN
survival following sensory cell loss can be significantly
enhanced by application of neurotrophic factors (NTF),
such as brain-derived neurotrophic factor (BDNF; Stae-
cker et al., 1996; Miller et al., 1997; Gillespie et al., 2003;
Shepherd et al., 2005) neurotrophin-3 (NT-3; Ernfors et
al., 1996), glial cell line-derived neurotrophic factor
(GDNF; Ylikoski et al., 1998; Altschuler et al., 1999; Yagi
et al., 2000), and combinations of neurotrophic factors
such as BDNF and fibroblast growth factor (FGF; Alts-
chuler et al., 1999) or BDNF and ciliary neurotrophic
factor (CNTF; Yamagata et al., 2004). NFT are also in-
volved in the formation and maintenance of afferent and
efferent cochlear connections (Fritzsch et al., 2004) during
normal development. The same NFT that enhance SGN
survival might then also induce the regrowth of their
peripheral processes, even in the absence of IHC (Ernfors
et al., 1996; Staecker et al., 1996; Altschuler et al., 1999;
Wise et al., 2005). Regrowth of peripheral processes could
enhance the integration of implant and auditory nerve,
increase electrode-nerve process proximity, lower excita-
tory thresholds, and increase selectivity of activation. This
could, in turn, improve efficacy and function of cochlear
prostheses. Previous studies, however, have used nerve
fiber markers that could not differentiate whether the
regrowth was from afferent processes of the auditory
nerve, from lateral and medial efferent processes to the
cochlea, or from some combination of afferents and effer-
ents. Regrowth of lateral or medial efferents would have
unknown benefit to the efficacy of cochlear prostheses.
This study is based on the hypothesis that neurotrophic
treatment selectively enhances afferent fiber regrowth
and uses selective markers that differentiate afferent and
efferent processes in the cochlea. Parvalbumin is a
calcium-buffering protein that in the cochlea selectively
labels SGN and their processes as well as IHC (Eybalin
and Ripoll, 1990; Soto-Prior et al., 1995; Pack and
Slepecky, 1995). Synaptophysin is a synaptic vesicle-
associated protein that provides specific labeling of olivo-
cochlear efferent fibers and terminals in the cochlea (Gil-
Loyzaga and Pujol, 1988; Nadol et al., 1993; Knipper et al.,
1995; Simmons et al., 1996; Counter et al., 1997). The
present study used parvalbumin as a marker for the pe-
ripheral processes of the auditory nerve and synaptophy-
sin as a marker for olivocochlear efferent peripheral pro-
cesses in immunocytochemical investigation of the
progression of deafness-associated changes in efferent and
afferent peripheral processes and the influence of chronic
intrascalar administration of BDNF and aFGF on re-
growth and maintenance of afferent vs. efferent processes.
MATERIALS AND METHODS
Study groups and design
Studies were performed in pigmented 250–350-g guinea
pigs of both genders from Elm Hill Breeding Labs
(Chelmsford, MA). Animals were housed in facilities ac-
credited by the Association for Assessment and Accredi-
tation of Laboratory Animal Care International, with free
access to food and water throughout the duration of the
experiment. Veterinary care and animal husbandry were
provided by the Unit for Laboratory Animal Medicine at
the University of Michigan, and all protocols were ap-
proved by the University Committee for the Use and Care
of Animals at the University of Michigan. Experiments
were performed in accordance with the guidelines of the
National Institutes of Health Guide for the care and use of
laboratory animals (NIH Publications No. 80-23, revised
1978). A concerted effort was made to minimize both the
number of animals used and the suffering of subjects
involved in the study.
Normal hearing by baseline acoustic auditory brain-
stem response (aABR 1) recording was necessary for in-
clusion in the study. Animals were then randomly divided
into eight groups (Fig. 1). Group 1 animals were non-
treated, normal hearing controls. Groups 2–8 were sys-
temically deafened with kanamycin (450 mg/kg) SQ fol-
lowed (2 hours later) with ethacrynic acid (60 mg/kg).
Deafness was confirmed by acoustic auditory brainstem
response (aABR 2) to a click stimulus (Miller et al., 2007)
with a 60-dB SPL threshold shift necessary for continued
inclusion (groups 2 and 4 were tested 3 days following
deafening; groups 3 and 5–8 were tested 5–7 days follow-
ing deafening). Groups 2, 3, and 6 received no further
treatment after they were deafened and were assessed 3,
7, and 21 days following deafening, respectively. Two
groups (groups 4 and 7) received NTF treatment. Group 4
received 26 days of chronic intrascalar infusion of BDNF
(100 g/ml) and aFGF (50 ng/ml) in one ear from a min-
iosmotic pump with a cannula into scala tympani (as in
Brown et al., 1993; Prieskorn and Miller, 2000), with
treatment starting 3 days following deafening (PD3 
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NTF) and assessment 29 days after deafening. Group 7
received 26 days of chronic intrascalar infusion of BDNF
and aFGF, with treatment starting 21 days following deaf-
ening (PD21  BDNF) and hence assessment 47 days
after deafening. The unimplanted ears in groups 4 (PD3 –
NTF) and 7 (PD21 – NTF) without NTF treatment served
as a control to assess contralateral effects of the drugs.
Groups 5 and 8 received 26 days of chronic intrascalar
infusion of artificial perilymph (AP) 3 days and 21 days
postdeafening and were assessed 29 and 47 days postdeaf-
ening. This experimental setup and the total amount of
animals (N) used in each group is summarized in Figure 1.
Assessments: coimmunolabeling of efferent
and afferent processes for confocal
microscopy
Three guinea pigs from each group were processed for
coimmunolabeling of afferent and efferent processes in the
organ of Corti. Guinea pigs were heavily anesthetized
with chloral hydrate and perfused through the left ventri-
cle with phosphate buffer followed by 4% paraformalde-
hyde in phosphate buffer. Temporal bones were carefully
removed, and cochleae then received local intrascalar fix-
ation with the same fixative followed by rinsing in buffer.
The otic capsule of the cochleae was removed in 0.1 M
phosphate-buffered saline (PBS; pH 7.4) using prepara-
tion needles and watchmaker’s tweezers. The remaining
cochleae were decalcified in 10% ethylenedinitrilotet-
raacetic acid disodium salt dihydrate (EDTA; Titriplex III;
Merck, Darmstadt, Germany) in PBS, pH 7.4, for 3–4
weeks, followed by rinsing in PBS. The stria vascularis,
Reissner’s membrane, and most bony parts near the mo-
diolus were removed using a curved Vannas microiris
scissor. The turns of the cochlea were cut into half coils
and transferred to small vials with plastic seals contain-
ing PBS.
Specimens were then rinsed several times in PBS with
0.3% Triton X-100 and 30% normal donkey serum (NDS)
to reduce nonspecific binding. The half coils were then
incubated in a mixture of antisynaptophysin (Sigma, St.
Louis, MO; S 5768; 1:1,000; as a marker for efferents) and
antiparvalbumin (SWant, Bellinzona, Switzerland; PVG-
214; 1:7,000; as a marker for afferent processes) in PBS
with 1% NDS and 0.3% Triton X-100 for 2 days at 4°C and
then 1 hour at RT. The monoclonal antisynaptophysin
antibody (IgG1 isotype) is derived from a hybridoma (clone
SVP-38) produced by fusion of mouse myeloma and
splenocytes mouse immunized with a synaptosome prep-
aration from rat retina and recognizes the 38-kDa band on
Western blot with rat brain extracts (manufacturer’s in-
formation). The polyclonal antiparvalbumin antiserum
was generated in goat against rat muscle parvalbumin
and recognizes the 12-kDa band on Western blots with
cerebellar extracts in rat and guinea pigs (information
kindly provided by Prof. Marco Celio, Division of Anat-
omy, University of Fribourg).
Cochleae incubated without primary antisera or with
antisera preabsorbed with the synthetic synaptophysin
peptide (10 M, 24 hours, 4°C) served as controls in each
experiment. The polyclonal antiparvalbumin antibody
produced a staining pattern in sections of the organ of
Corti and spiral ganglion of normal hearing guinea pigs
that is identical to that previously reported (Eybalin and
Ripoll, 1990; Soto-Prior et al., 1995; Pack and Slepecky,
1995). After rinsing in PBS (five times, 10 minutes each),
the specimens were then processed with a mixture of the
secondary antibodies [Cy5 donkey anti-mouse IgG; 1:800;
code 715-175-150 from Jackson Immunoresearch (West
Grove, PA) and Alexa Fluor 488 donkey anti-goat IgG
1:2,000; catalog No. A11055 from Molecular Probes (Eu-
gene, OR)] in PBS containing 1% NDS for 2 hours at RT in
a dark chamber. Based on immunoelectrophoresis, Cy5
Fig. 1. Animal groups used in this study. aABR1 confirmed nor-
mal hearing prior to deafening procedure; aABR2 confirmed a 60-dB
shift in threshold after kanamycin/ethacrynic acid deafening. Group 4
(immediate treatment, PD3  NTF) and group 7 (delayed treatment,
PD21  NTF) received BDNF and aFGF into one ear. The contralat-
eral ears (PD3 – NTF and PD21 – NTF) received no treatment. PD,
days postdeafening; AP, artificial perilymph for 26 days prior to
sacrifice; aABR, acoustic auditory brainstem response; N, total
amount of animals used in each group. [Color figure can be viewed in
the online issue, which is available at www.interscience.wiley.com]
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donkey anti-mouse antibody reacts with the heavy chains
on mouse IgG and with light chains common to most
mouse immunoglobulins. No antibody was detected
against nonimmunoglobulin. Alexa Fluor 488 donkey anti-
goat reacts with IgG heavy chains and all classes of im-
munoglobulin light chains from goat (both manufacturer’s
information). After rinsing again in PBS (five times, 10
minutes each) the whole-mount preparations were cov-
ered with Vectashield Mounting Medium (Vector Labora-
tories, Burlingame, CA). Corresponding cochlear turns of
each ear from the same animal were exposed simulta-
neously to the same solutions to ensure equal treatment of
NTF-treated and untreated contralateral ears.
Sections were analyzed on a Zeiss LSM 510 Meta laser
scanning microscope (LSM) with software release 3.2.
Frame size was set as predefined number of pixels
(1,024  1,024 pixels are used), and color depth was set to
eight bit. Z-stacks through the whole organ of Corti were
made with a Zeiss PlanNeofluar 40, 1.3, DIC using the
488-nm line of an argon/krypton 30-mW laser set to 21%
output power for excitation of Alexa 488 and a 5-mW
helium neon laser 633 nm (80% output power) for excita-
tion of Cy5. Confocal stacks were acquired in single-track
line scan mode unidirectional, using separate channels.
An NTF 545 beam splitter and 505–550-nm bandpass
filter were used for Alexa 488 detection and a 650-nm
longpass filter for Cy5, respectively. Additionally the
transmitted light channel was recorded to visualize non-
immunostained tissue structures. Pinholes were set to 1
airy units, detector gain, and amplifier offset was adjusted
using the range indicator function of the Zeiss software.
Amplifier gain was set to 1, and line scans were set to four
times mean average with a scan speed of 1.6 sec pixel
time. Corresponding cochlear turns of the same animal
were recorded sequentially with the identical microscope
settings. For visualization, xy-projections of the z-series
confocal stacks into one plane were performed with the
LSM510 software. Red and green fluorescence was
merged with the Zeiss LSM software and exported as TIF
files. Conversion into magenta-green was performed with
Adobe Photoshop CS by coping the red channel into the
blue channel of the RGB image.
Assessments: image analysis of
coimmunolabeling of efferent and afferent
processes for confocal microscopy
Parvalbumin immunoreactivity was semiquantitatively
assessed by using the image-analysis software Image Pro
6.0 (Media Cybernetics, Silver Spring, MD) with 3D con-
structor extension package (AMD Opteron workstation; 8
GB RAM, Nvidia 6800 Ultra graphic board, Windows XP
professional 64-bit edition). Alexa 488 fluorescence was
extracted as a gray image stack, subsampled 2:2:1 (x:y:z)
and filtered with a LoPass 3  3  3 filter. No other prior
filtering or deconvolution was done with the data sets.
Isosurface values were defined interactively for one spec-
imen and set as default for the contralateral ear. Isosur-
faces and volumes were generated using the automatic
close-edge function of the software and exported to a Mi-
crosoft Excel datasheet. Organ of Corti length (OL) was
measured at the level of the inner spiral bundle orientat-
ing at synaptophysin immunoreactivity. The ratio of vol-
ume of parvalbumin immunoreactivity (Vparv) to OL per
image stack served as a comparative measure. The sum of
Vparv/OL of 1a and 1b half turns was used to compare
ears treated with BDNF/aFGF and contralateral un-
treated ears. Additionally, the amounts of parvalbumin-
positive puncta per 100 m organ of Corti length are
given. Analysis of variance between BDNF/aFGF and con-
tralateral untreated ears within the same animal was
tested with Student’s t-test to find statistical significant
differences in mean Vparv/OL in the basal turn.
This evaluation allows us only semiquantitatively to
compare the two ears of the same animal, because the
setups of preparation (use of the same washing, blocking
and antibody solutions, and incubation conditions) and
acquisition (identical microscope settings) were equal.
Specimens prepared and assessed on another day with
minimal diverging preparation and acquisition conditions
cannot be compared with fluorescence labeling. Photo-
bleaching during image acquisition was assumed to be
approximately the same for corresponding cochlear turns.
Only 1a and 1b half-turns excluding the hook region of the
sensory epithelium were used for this assessment.
Assessments: preembedding synaptophysin
and parvalbumin immunoperoxidase
staining for light and electron microscopic
assessment
Three to seven animals from each group (groups 4, 5, 7,
8  six or seven animals; groups 1–3, 6  three or four
animals) were processed for preembedding immunoperox-
idase staining for synaptophysin and parvalbumin with
assessments at the light and electron microscopic levels.
Animals received vascular perfusion as described above
but with fixative containing 4% paraformaldehyde and
0.5% glutaraldehyde in cacodylate buffer. Otic capsule,
Reissner’s membrane, and stria vascularis were removed.
Decalcification with EDTA was performed as described
above. After being thoroughly washed in PBS, cochleae
were microdissected perpendicular to the radial plane into
hook region, basal turn, second turn, and apex, followed by
radial bisection paramodiolar. (The half-turns containing
the modiolus of these specimen were also used for assess-
ment of spiral ganglion neurons; see below.) Specimens
were rinsed either in 10% normal goat [for synaptophysin-
like immunocytochemistry (ICC)]: efferent marker, mono-
clonal, generated in mouse; Sigma; S 5768) or donkey
serum (for parvalbumin-like ICC: afferent marker, poly-
clonal, generated in goat; SWant; PVG-214), both contain-
ing an additional 1% bovine serum albumin (BSA; lyoph-
ilized albumin bovine fraction V; Serva, Heidelberg,
Germany) to reduce nonspecific binding sites and 0.25%
Triton X-100 (Roche 789704) in 50 mM Tris-HCl-buffered
saline (TBS). The primary antibody was diluted 1:1,000
for antisynaptophysin and 1:7,000 for antiparvalbumin
(for description of antibodies see above), and cochleae were
incubated for 2–3 days at 4°C, then for 2 hours at room
temperature. Detection of primary antibodies was per-
formed with suitable Vectastain Elite ABC kits (Vector,
Burlingame, CA). After the specimens were rinsed five
times in TBS, a peroxidase-conjugated antibody raised
against the primary antibodies (biotinylated anti-mouse
made in horse from PK-6102 kit or anti-goat made in
rabbit from PK-6105 kit; IgG, 1:200) was applied for de-
tection followed by an avidin horseradish peroxidase com-
plex (1:75 from Vectastain Elite ABC kit) according to the
manufacturer’s protocol. Peroxidase activity was revealed
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by using 0.05% 3,3-diaminobenzidine (DAB; Sigma, Mu-
nich, Germany) as a chromogen and 0.04% perhydrol as
substrate (H2O2 30%; Merck, Darmstadt, Germany) with
cobalt chloride to intensify staining.
Specimens were then processed according to standard
technique for transmission electron microscopy (TEM).
Whole mounts were fixed in Karnovsky’s fixative (5% glu-
taraldehyde and 4% paraformaldehyde in cacodylate
buffer) overnight and then received four 15-minute
washes in 0.1 M cacodylate buffer, followed by postfixation
with 1% osmium tetraoxide in 0.05 M cacodylate buffer for
1 hour (at 4°C). Excessive osmium tetraoxide was removed
by rinsing the specimens four times (15 minutes each) in
0.1 M cacodylate buffer. The specimens were then dehy-
drated in a series of ethanols (2  70% ethanol each 15
minutes, 2  96% ethanol each 15 minutes, 2  100%
ethanol each 15 minutes). Propylene oxide was used as an
intermedium (2  15 minutes), prior to incubation in a
dilution of liquid epoxy resin (according to Spurr, 1969)
and propylene oxide in equal shares overnight in closed
vials. On the next day, the mixture was replaced by 100%
epoxy resin and changed twice (1 hour each in a vacuum
chamber). Specimens were then transferred to an embed-
ding mold, labeled, and placed in a vacuum chamber for an
additional 1 hour. After checking the orientation of the
half-coils under a stereomicroscope, the specimens were
transferred to an incubation chamber at 60°C for 48 hours
to increase the polymerization of the epoxy resin.
One-micrometer sections were cut on a Leica Ultracut
microtome, lightly stained with toluidine blue at 60°C,
and then examined using a light microscope. Radial sec-
tions were used for assessment of immunoperoxidase
staining; in the midmodiolar plane, these sections were
also used for SGN assessments. Specimens for TEM were
trimmed and ultrathin sections (90 nm) acquired and
transferred to Formvar-coated slot grids. These were ex-
amined with a Zeiss Libra 120 transmission electron mi-
croscope at 80 kV (Division of Ultrastructural Research
and Evolutionary Biology, Institute of Zoology, Leopold
Franzens University, Innsbruck).
Assessments: SGN and peripheral nerve
fibers
The portion of the cochlear half-turn containing the
modiolus of the immunoperoxidase-embedded tissues (see
above) was used for SGN assessment. One-micrometer-
thick sections in a paramodiolar plane were acquired with
a Leica Ultracut microtome. Once a midmodiolar plane
was reached, three 1-m sections were acquired at 30-m
intervals, mounted on glass slides, and Nissl stained with
toluidine blue at 60°C on a hotplate.
Three slides per cochlear turn were therefore used for
each of the three to seven animals in each group. Two
profiles per cochlear turn through Rosenthal’s canal were
assessed for each slide (two for first turn, two for second
turn, two for upper turn). SGN in the hook region and
apical end were excluded. Digital images of the entire
profile were acquired in Image-Pro 6.0 (Media Cybernet-
ics) linked to a 3-CCD color video camera (Sony DXC-
950P) and an Olympus BX50 light microscope. The outline
of the Rosenthal’s canal profile was then traced, and the
area, excluding the area of blood vessels, measured. Each
SGN was counted. The SGN density expressed as the
density of SGN for an area of square millimeters was then
determined. The arithmetic mean of longest and shortest
diameter per SGN of the 10 largest cells per Rosenthal’s
canal view was determined. The mean density and mean
diameter of SGN was assessed for each profile and dis-
played as box plot diagrams. The box contains 50% of the
data; the upper edge of the box indicates the 75th percen-
tile of the data set, and the lower hinge indicates the 25th
percentile. The line in the box points to the median value
of the data; “whiskers” indicate the minimum and maxi-
mum data values, excluding suspected outliners (not
shown).
Analysis of variance between animal groups on spiral
ganglion density data were tested with a one-way
ANOVA, and post hoc Student-Newman-Keuls test served
to find statistical significant differences in the mean den-
sity. Differences associated with P values less than 0.05
were considered to be statistically significant and are dis-
played in the diagrams as horizontal (no significant dif-
ference between selected animal groups) and vertical bars
(statistically significant difference between selected ani-
mal groups). Tangential sectioning of the OSL gave a
cross-sectional view of most peripheral nerve fibers to
estimate nerve fiber loss and effect of NTF treatment.




Two animals of each NTF treated group and two normal
hearing animals were fixed with Karnovsky’s solution (4%
paraformaldehyde and 5% glutaraldehyde in 0.1 M caco-
dylate buffer, pH 7.3–7.4) and processed for standard
TEM as described above. This ensured optimal fixation
quality for ultrastructure. The myelin layers of 20 type I
neurons of each Karnovsky’s-fixed temporal bone were
counted in the basal turn to detect demyelination. Adjust-
ments to brightness and contrast of light and electron
micrographs were performed in Adobe Photoshop CS, and
micrographs were stored as uncompressed eight-bit TIF
files.
RESULTS
Hair cell loss and organ of Corti scar
formation
Deafening with ototoxic drugs (kanamycin and
ethacrynic acid) was effective in inducing loss of IHC and
OHC, with resulting scar formation in the sensory epithe-
lium (outer hair cells) replacing the lost hair cells. There
was a base-to-apex gradient in the thickness of the scar
formations in all deafened animals (not shown) and a
change in the appearance of the scar over time following
deafening (Fig. 2), consistent with the literature (Hawkins
and Engstroem, 1964; Johnsson and Hawkins, 1976;
Bohne, 1977; Nadol, 1977; Raphael and Altschuler, 1991,
1992). In the basal turn at 3 days following deafening (Fig.
2B), no OHC and only few IHC or IHC remnants were
present (two animals with IHC survival were excluded
from the study). At 7 days following deafening (Fig. 2C),
supporting cells such as tectal cells, inner and outer sulcus
cells, or collapsed pillar cells were still distinguishable. At
21 and 29 days following deafening, in 50% of animals
there was only a single layer of cells remaining in the
basal portion of the first turn, whereas, more apically in
the first turn, there was thicker scar formation with dis-
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tinct supporting cells, comparable to the 7-days-
postdeafening animal group. The other 50% of animals
had an intermediate thickness of scar tissue (Fig. 2D,E)
across the whole basal turn. By 47 days following deafen-
ing, sensory epithelium of the scar was reduced to only one
flattened layer of cells (Fig. 2F) in all nontreated animals.
In ears treated with neurotrophins (Fig. 2G–I), the scar
formations never reached the single layer of cells seen in
untreated animals. Most animals showed a thick scar
formation with readily distinguishable supporting cells in
the basal and higher turns in the NTF-treated ears. In
some animals, new tissue formation bulging into the scala
tympani at the level of the habenula perforata could be
observed from lower basal (Fig. 2I) to upper middle turn,
seen in both group 4 (receiving NTFs at either 3 days
following deafening; PD3  NTF) and group 7 (receiving
NTFs at 21 days following deafening; PD21  NTF) on
their NTF-treated ears. Contralateral untreated ears
(PD3 – NTF, PD21 – NTF) showed morphology compara-
ble to that of untreated animals (PD29, PD47).
Peripheral nerve fiber loss
As hair cells are lost, peripheral nerve fibers degenerate
over time (Fig. 3A–C), as seen in tangential sections. At 3
days following deafening, there remained a high density of
myelinated processes in the osseous spiral lamina (Fig.
3A) that gradually decreases to fewer nerve fibers 47 days
postdeafening (Fig. 3C). Both immediate and delayed NTF
treatment (Fig. 3D,E) not only prevents this degeneration
but also leads to a regrowth of fibers into the scala tym-
pani. In two animals with some fibrous tissue in 1a turn,
this outgrowth was seen more frequently (Fig. 3D), and
nerve fibers in the scala tympani make up a myelin layer.
The cells between myelinated and unmyelinated nerve
fibers shared the morphology of Schwann cells at the EM
level (Fig. 3E).
Parvalbumin immunolabeling in normal
hearing, untreated animals
There was parvalbumin immunolabeling of afferent pe-
ripheral processes and IHC in the cochlea of normal hear-
ing animals, consistent with the staining pattern in the
cochlea from the literature (Eybalin and Ripoll, 1990;
Soto-Prior et al., 1995; Pack and Slepecky, 1995). In plas-
tic cross-sections through immunoperoxidase-stained sur-
face preparations (Fig. 4), there was parvalbumin immu-
nostaining of afferent peripheral processes streaming
through the osseous spiral lamina via the habenula per-
forata (Fig. 4A,B), forming rosettes of terminals under
IHC. IHC (Fig. 4A) were also parvalbumin immunolabeled
as well as basal cells in the stria vascularis, which distin-
guishes them from the melanin granules in the interme-
diate cells layer (Fig. 4D). The afferent nerve endings
beneath OHC and basal tunnel crossing fibers were not
immunolabeled with parvalbumin, indicating that the
processes of type II SGN innervating OHC were not parv-
albumin positive. Whereas type I SGN and the myelinated
nerve fibers might be expected to be immunolabeled, there
Fig. 2. A–I: Scar formation of the sensory organ postdeafening in
the lower basal turn (1a). Deafening leads to a rapid loss of hair cells
3 days postdeafening (PD3). Until PD7, the scar formations are rather
thick and contain some distinguishable supporting cells. Sensory ep-
ithelial remnants flatten 21 and 29 days postdeafening and are re-
duced to a single cell layer in PD47 animals. Immediate and delayed
NTF treatment can lead to both a fairly thin epithelial layer (G,H) and
thick scars with new tissue formation close to the habenula perforata
(I, asterisk). Scale bars  50 m. [Color figure can be viewed in the
online issue, which is available at www.interscience.wiley.com]
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Fig. 3. Peripheral nerve fiber loss and neurotrophic treatment in
the lower basal turn. A,B,C,D are semithin sections; E,F are electron
micrographs; framed area in Fig. F represents the more highly mag-
nified view in E. A considerable loss of myelinated nerve fibers occurs
between 3 and 47 days postdeafening (A–C). NTF-treated animals
(D,E,F) show high nerve fiber densities and outgrowth of fibers into
the scala tympani (D, arrows) that contains some fibrous tissue (D–F).
Cells between nerve fibers share the morphology of Schwann cells (E)
and ensheath myelinated as well as unmyelinated (asterisks) nerve
fibers. Scale bars  10 m. [Color figure can be viewed in the online
issue, which is available at www.interscience.wiley.com]
was only scattered immunolabeling, with most SGN unla-
beled. This is likely methodological, a consequence of a lack
of antibody access to the modiolus as well as the thick myelin
sheet around SGN and their nerve fibers, which can prevent
sufficient penetration of antibodies when using preembed-
ding staining on whole cochleae.
The typical pattern of parvalbumin immunolabeling
was also seen with immunofluorescent labeling of surface
preparations (Fig. 5A), where there was immunolabeling
of IHC and labeling of afferent processes in form of puncta
at IHC bases. There was no immunolabeling in the OHC
region.
No parvalbumin-immunostained fibers, terminals, cells,
or structures coimmunolabeled with synaptophysin in
surface preparations (parvalbumin green, synaptophysin
magenta; colabeling if present would be white) wee seen
with confocal microscopy (Fig. 5A). This confirms the se-
lectivity of synaptophysin and parvalbumin as markers
for differentiating efferent vs. afferent fibers and termi-
nals. In control preparations of inner ears without pri-
mary antisera or antisera preabsorbed with the synthetic
synaptophysin peptide, no synaptophysin- or parval-
bumin-like immunoreactivity was observed on surface
preparations or in semi- and ultrathin plastic sections.
Synaptophysin immunolabeling in normal
hearing, untreated animals
There was synaptophysin immunolabeling of both me-
dial and lateral efferent fibers and terminals in the organ
of Corti of normal hearing animals, consistent with the
staining pattern reported in the literature (Gil-Loyzaga
and Pujol, 1988; Nadol et al., 1993; Knipper et al., 1995;
Simmons et al., 1996; Counter et al., 1997). In plastic
cross-sections through immunoperoxidase-stained surface
preparations (Fig. 4E–G), synaptophysin-immunostained
lateral efferent fibers and terminals can be seen in the
inner spiral bundle under IHC and in the tunnel spiral
bundle (Fig. 4E,F), and medial efferent terminals at the
OHC bases were also immunostained. In immuno-
fluorescence-stained surface preparations viewed with the
LSM (Fig. 5A), there was synaptophysin immunolabeling
(red) of lateral efferents in the inner and tunnel spiral
bundles and of medial efferents in tunnel crossing fibers




PD3. Surface preparations with synaptophysin (ma-
genta) and parvalbumin (green) immunostaining revealed
a loss of IHC and a decrease in afferent but not efferent
processes at 3 days following deafening. There was a large
decrease in parvalbumin-immunostained afferent pro-
cesses and endings, with the greatest decrease in basal
turns and less decrease in apical turns (Fig. 5B–D). An
occasional parvalbumin-immunostained hair cell was ob-
served in surface preparations (Fig. 5B–D), perhaps re-
flecting a delay in IHC death (because no IHC were ob-
Fig. 4. Parvalbumin and synaptophysin immunoreactivity in the
normal guinea pig cochlea. A–C,F,G are electron micrographs;
D,E are semithin sections (E not counterstained). Parvalbumin LI
stains afferent processes as they loose their myelin sheet close to
habenula perforata and their target, the IHC (A,B). SGN are also
immunopositive (C), and antibody penetration is impeded by the
myelin sheet. Basal cells in the stria vascularis show immunoreactiv-
ity for parvalbumin (D) that distinguishes them from the melanin
granules in the intermediate cell layer (asterisks). Synaptophysin
ICC stains medial (MOC) as well as lateral (LOC) olivocochlear nerve
fibers (E), which are efferents below the IHC (lateral efferents), the
tunnel spiral bundle (TSB), and fibers originating from the medial
olivary complex, especially the medial efferent terminals below the
OHC (G, arrows). Scale bars  10 m in A,C; 5 m in B,F,G; 20 m
in D; 25 m in E.
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served in later periods following deafening) or perhaps
immunostaining of a remaining hair cell fragment. IHC
remnants as well as IHC could occasionally been detected
in semithin sections (not shown). There was no perceptible
loss of synaptophysin-immunostained medial or lateral
efferents at 3 days following deafening (Fig. 5B–D), with
no change in the appearance of the inner or tunnel spiral
bundles (lateral efferents) and all three rows of immuno-
Fig. 5. A–P: Confocal microscopy of peripheral processes within
the sensory epithelium: base-to-apex degeneration pattern. Parvalbu-
min LI green, synaptophysin LI magenta. Confocal projections in
normal hearing animals (A) display IHC and more intense puncta
representing afferent processes originating from type I neurons.
Three rows of red puncta in the upper half of the picture represent
efferent terminals innervating OHC. Lateral efferents are mostly
hidden behind parvalbumin LI. PD3 cochleae (B) display the dramatic
loss of IHC, reduced to some IHC remnants (RIHC). OHC are com-
pletely lost (not stained), but medial efferent fibers still persist
throughout all cochlear turns (C,D). Inner spiral bundle (ISB),
tunnel spiral bundle (TSB), and MOC fibers are clearly distinguish-
able. PD7 animals reveal less parvalbumin LI in the lower basal (E)
compared with higher turns (F,H). Typical efferent base-to-apex
gradient displays almost complete loss of immunoreactivity of me-
dial efferents in the lower basal turn in PD21 (I) and PD47 (M)
animals and higher synaptophysin LI in more apical turns (J–L,N–
P). Scale bars  50 m.
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stained medial efferent puncta remaining in the OHC
region, even in the absence of OHC. As in the normal
hearing cochlea, there was no colocalization of synapto-
physin and parvalbumin in any cells, fibers, or structures,
indicating that the deafening did not induce a change in
phenotype and that synaptophysin and parvalbumin re-
main useful as selective markers.
PD7. At 7 days following deafness, there was a contin-
ued decrease in parvalbumin-immunostained afferent
processes and puncta, with the greatest loss in the basal
turn (Fig. 5E–H). Synaptophysin-immunostained effer-
ents remained relatively unaffected at 7 days following
deafening in most animals, with normal-appearing inner
and tunnel spiral bundles. Some loss of medial efferent
puncta, particularly in the third row, was clearly visible.
PD21–PD47. Between 7 and 21 days following deafen-
ing, there was a dramatic loss of parvalbumin-
immunostained afferent processes. At 21 days (Fig. 5I–L)
and continuing at 29 (not shown) and 47 days (Fig. 5M–P)
following deafening, parvalbumin immunostaining was
almost completely absent across all turns of the cochlear
spiral, except for rare and scattered fibers and puncta. No
immunostained IHC were observed. At 21 days following
deafening, the first obvious changes in synaptophysin-
immunostained efferents were observed (Fig. 5I–L), pre-
dominantly in the basal turn. Although inner and tunnel
spiral bundle had a normal appearance, there were only a
few remaining medial efferent puncta in the OHC region,
when present only in one row. It was not until 47 days
following deafening (Fig. 5M–P) when immunolabeling of
inner and tunnel spiral bundles diminished in most ani-
mals (more in base than in apex), and there was a large
loss of medial efferent puncta across all turns.
In summary, after deafening with IHC loss, the afferent
nerve fiber system degenerates rapidly, with a massive
loss of afferent processes between 7 and 21 days postdeaf-
ening within the scar region. The lateral efferents are the
most resistant, with little change at 21 days postdeafen-
ing, despite loss of their targets, and with immunostaining
still present at 47 days following deafness, greater in more
apical than more basal turns (Fig. 5I–P). Medial efferent
terminals in the OHC region decrease at 21 days following
deafening, greatest in the more basal turns (Fig. 5I–L),
perhaps associated with the progression of the scar forma-
tion, with a flattened, thin epithelium in that position.
Influence of BDNF/aFGF treatment on
deafferentation-induced changes:
immunofluorescent labeling of surface
preparations
There was a large increase in the parvalbumin immu-
nostaining in animals receiving chronic intrascalar
BDNF/aFGF starting at 3 days following deafness, com-
pared with untreated contralateral ears or untreated deaf-
ened animals. In immunostained surface preparations in
both basal and more apical turns, there were numerous
parvalbumin-immunostained puncta in treated animals
compared with few in the untreated cochlea of the same
animal (Fig. 6A–D, Table 1). A similar difference was seen
when comparing animals receiving chronic intrascalar
BDNF/aFGF starting at 21 days following deafness. Im-
munostained surface preparations showed numerous
parvalbumin-immunostained puncta in treated animals
compared with few in untreated ears of the same animals
in both basal (Fig. 6E,F, Table 1) and more apical (Fig.
6G,H) turns.
Isosurface rendering of the data sets (Fig. 6 I–K) clearly
displays distribution and size of immunoreactivity of the
marker antibodies in normal and immediately- and
delayed-NTF-treated animals. The significant effect of
NTF is clearly demonstrated by semiquantification using
isosurface rendering and volumetric evaluation of the en-
tire basal turn (Table 1). BDNF/aFGF treatment provides
a significant increase in parvalbumin immunostaining in
treated vs. untreated ears of the same individual, with the
increase ranging from two- to sevenfold.
NTF-treated animals show two to five times more
parvalbumin-positive puncta along the basal turn than in
the untreated contralateral ears (Table 1), and parvalbu-
min immunoreactivity is present more far distally in the
scar region at sites where there are no afferents in normal
hearing animals (Fig. 6K).
There are no quantitative or qualitative differences in
immunofluorescent labeling of the efferent marker synap-
tophysin in the surface preparations in NTF-treated ears
or contralateral untreated ears and no qualitative alter-
ations compared with the control groups (PD29 and
PD47). Thus the medial efferent system does not appear to
be greatly influenced by NTF treatment.
Influence of BDNF/aFGF treatment on
deafferentation-induced changes:
immunoperoxidase labeling in plastic
sections (LM and TEM)
Plastic sections through NTF-treated animals revealed
parvalbumin immunostaining far distally and also proxi-
mally to the habenula perforata, at sites where no afferent
nerve fibers are present in untreated and normal hearing
animals. Positive staining was observed in the basal turn
as far as inner sulcus cells adjacent to the tectorial mem-
brane (Fig. 7A–C) and radially sprouting into the tectal
cell area (Fig. 7B,C). At the transition from the bony
columns that guide nerve fascicles from Rosenthal’s canal
to the habenula, an outgrowth of parvalbumin-
immunostained afferent fibers into the scala tympani can
be observed (Fig. 7B–D). In some animals, the amount of
new tissue formation leads to a considerable bulge into the
perilymphatic compartment (Fig. 7D). This was found
only in the first and even more frequently in the second
turn of the cochlear spiral. The neurotrophic effect on
nerve fiber regrowth in the more apical region was less
effective, although some animals also showed high levels
of parvalbumin immunoreactivity (Fig. 7E) with equal
staining pattern for parvalbumin observed in the basal
turn. Nerve fibers were found in treated animals that
progressed into the scala via canaliculi perforantes, small
fenestration in the bone of Rosenthal’s canal, and bony
columns guiding nerve fibers to the osseous spiral lamina
(Fig. 7F). These fibers reveal a myelin layer close to the
spiral canal and within the bony canaliculi but with ex-
treme swelling when entering the scala typani.
TEM assessment of ultrastructure confirmed immuno-
reactivity for parvalbumin within most regrown nerve
fibers in the bulging tissue and fibers traveling between
bone and mesothelial cells (Fig. 8A,B). Although fibers are
surrounded by satellite cells (Fig. 8A), there are no myelin
layers visible. Fibers in the habenula perforata showed
higher levels of immunoreactivity in their axoplasm (Fig.
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8C). Often these afferent fibers showed swellings as they
entered the scar tissue, reminiscent of afferent terminals
beneath IHC in normal hearing animals that often swell
due to glutamate toxicity. Karnovsky-fixed tissue con-
firmed the presence of nerve fibers in the inner sulcus
displaying typical morphologic characteristics (Fig. 8D).
Although no effects of NTF treatment on synaptophysin
immunostaining were noted in immunofluorescence-
labeled surface preparations, differences were found in
immunoperoxidase-labeled plastic sections. Positive syn-
aptophysin immunostaining was present in the vicinity of
inner pillar remnants and in the osseous spiral lamina
(Fig. 9A) in animals with and without NTF treatment.
However, only in animals with NTF treatment and thicker
scar tissue was synaptophysin immunolabeling observed
in the inner sulcus region (Fig. 9B,C) as well as in “bulges”
of tissue in the mesothelial layer lining the scala tympani
(Fig. 9B). TEM confirmed synaptophysin LI to be assigned
to nerve fibers (Fig. 9D).
SGN: changes with deafness and influence
of BDNF/aFGF
The number of SGN progressively decrease over time
following deafening in untreated animals (Figs. 10, 11). A
base–apex gradient in the onset of loss is evident, with
decreases appearing more rapidly in basal turns. There is
a 50% decrease across turns at 47 days following deafen-
ing. In the group of animals receiving BDNF and aFGF for
Fig. 6. A–K: Effect of BDNF/aFGF treatment on peripheral pro-
cesses. Parvalbumin LI green, synaptophysin LI magenta. Immediate
(A–D) and delayed (E,F) NTF treatment results in higher immunore-
activity for parvalbumin (green), with more widespread puncta along
the cochlear spiral compared with corresponding contralateral ears of
the same individual (B,D,F,H). Isosurface rendering of confocal image
stacks (I–K) clearly visualizes size and localization of immunoreactiv-
ities in normal hearing (I) and immediately (J)- and delayed (K)-NTF
treated animals. The PD21  BDNF ear shows tendencies for a more
distal spread of parvalbumin LI (K, arrows). Scale bars  50 m.
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TABLE 1. Semiquantitative Volumetric Assessment of Parvalbumin LI in NTF-Treated Animals in the Basal Turn1
Specimen Vparv/m Puncta/100 m Specimen Vparv/m Puncta/100 m t-Test  Vparv
1: PD3  NTF 12.7 38.9 1: PD3–NTF 5.2 22.2 0.023
2: PD3  NTF 24.4 60.6 2: PD3–NTF 7.3 12.5 0.001
3: PD3  NTF 37.0 59.0 3: PD3–NTF 5.1 14.6 0.022
4: PD21  NTF 15.7 43.7 4:PD21–NTF 7.0 25.4 0.003
5: PD21  NTF 24.8 52.1 5:PD21–NTF 7.1 24.8 0.006
6: PD21  NTF 12.7 28.1 6:PD21–NTF 2.6 13.6 0.001
1Isosurface rendering and calculation of the volume of parvalbumin-LI per micrometer organ of Corti (Vparv/m) of three specimens immediately treated with NTF (specimens
1-3; PD3  NTF) and three animals with delayed neurotrophic treatment (specimens 4-6; PD21  NTF). Contralateral untreated ears of the same individual are given alongside
(PD3 – NTF and PD21 – NTF ). The number of parvalbumin puncta (puncta/100 m organ of Corti) are given for each cochlea. Turns 1a and 1b were used for this assessment.
Student’s t-test served to assess whether the Vparv/m values for contralateral ears are statistically different from each other (t-test Vparv).
Fig. 7. Regrowth of nerve fibers. Semithin sections of NTF-treated
ears processed for immunohistochemistry to detect parvalbumin (F, neg-
ative control). Immediate treatment (A,B) and delayed administration
(C–F) of BDNF/aFGF results in immunopositive fibers within the scar
formation of the former sensory epithelium (solid arrows) as well as in
newly formed tissue bulging into scala tympani (open arrows). This could
be observed in the basal (A,C) as well as the middle (B,D) turn, in some
animals also in the apex (E). Single nerve fibers even penetrate through
canaliculi perforantes at the modiolar wall into scala tympani (F). Scale
bars  20 m in A–C,F; 10 m in D,E.
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26 days starting 21 days following deafening, there was no
significant loss of SGN in all turns. Immediately-treated
animals show some loss of SGN compared with normal,
most pronounced in the upper turns (Fig. 10). Both NTF-
treated groups show a significant increase of SGN density
compared with untreated deafened cochleae or animals
receiving artificial perilymph. Moreover, in delayed-NTF-
treated animals, mean SGN density in the basal turn was
even higher than in normal hearing subjects (normal 
1,425 SGNmm2; PD21  NTF  1,675 SGNmm2; P 
0,001). Middle and upper turns in the PD21  NTF ears
had SGN densities comparable to those of normal hearing
animals. The treatment was less effective in animals with
treatment starting at 3 days following deafness, where
there was less survival. Contralateral ears from NTF-
treated animals (PD3 – NTF and PD21 – NTF) and cor-
responding control animals (PD29 and PD47) did not show
any significant difference in SGN density, suggesting no
contralateral effect of the neurotrophic drugs. Data and
significant differences between selected animal groups are
summarized in Figure 10.
An increase in spiral ganglion size has been reported
with BDNF treatment (McGuinness and Shepherd, 2005).
The current study showed a trend toward an increase in
Fig. 8. Regrowth of afferent nerve fibers: transmission electron
microscopy. Parvalbumin LI in PD21  NTF cochleae (A–C). A,B:
Within newly formed tissue bulging into the scala tympani (ST),
immunoreactivity can be assigned to nerve fibers. A: Some fibers are
negative (asterisk), but most show immunostaining (solid arrows).
Regrown nerve fibers are bordered by a mesothelial cell (m) sheet
lining perilymphatic spaces. Fibers are ensheathed by satellite cells
(open arrows) that do not contain myelin layers. B: A single
parvalbumin-positive fiber (a) travels in a spiral direction between the
bony modiolar wall (bo) and the mesothelial cell sheet (m). C: As nerve
fibers penetrate the basilar membrane (BM) via the habenula perfo-
rata (hp), afferent peripheral processes often show swelling, compa-
rable to artifacts on afferent terminals below IHC in normal hearing
animals (not shown). D: Karnovsky’s fixation demonstrates fibers in
the inner sulcus region (see inset showing a lower magnification
overview; open arrow) to be neuronal structures with typical morphol-
ogy for nerve fibers (open arrows). Scale bars  2 m in A,B,D; 5 m
in C.
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SGN size in the basal turn of cochleae from animals re-
ceiving BDNF and aFGF starting either 3 days or 21 days
following deafening (Fig. 12). Delayed NTF treatment re-
sulted in increased ganglion size throughout all cochlear
turns. Immediate treatment resulted in larger neurons
only in the basal turn and decreased mean diameters in
more apical turns compared with normal. Data and sig-
nificant differences between selected animal groups are
summarized in Figure 12. Quantification of Rosenthal’s
canal and blood vessel area did not show any significant
difference among animal groups.
Qualitative comparison of delayed NTF treatment and
its untreated control group 8 (PD47) demonstrates a strik-
ing effect of BDNF and aFGF (Fig. 13). Different stages of
apoptosis in several neurons and large intercellular
spaces distinguish the spiral ganglion of untreated ani-
mals from NTF exposition with big neurons that squeeze
into available spatial gaps in Rosenthal’s canal. Aggrega-
tion or loose distribution of Nissl bodies within cytoplasm
could be detected in all animal groups, comparable to that
in normal hearing animals. Increased perikaryal size goes
together with larger nuclei (approximately 10–15%; 100
SGN measured).
Electron microscopy of Karnovsky’s-fixed tissue reveals
only few aberrant morphologic structures at the subcellu-
lar level. In type I neurons, distribution and cytoplasmatic
content such as Nissl substance, mitochondria, and ribo-
somes resemble those in normal control animals (Fig.
Fig. 9. Synaptophysin LI with neurotrophic treatment.
A–C: Semithin sections. D: Electron micrograph. Synaptophysin
immunostaining is present in most animals only in the former
region of the inner spiral bundle and tunnel spiral bundle (A,D).
Some animals show immunostaining also at the inner sulcus (ar-
rows, B,C) and regrown fibers adjacent to the scala tympani (open
arrows, B) and show weak synaptophysin LI. Scale bars  20 m in
A; 30 m in B; 10 m in C; 1 m in D.
Fig. 10. Quantitative analysis of spiral ganglion neurons in basal,
middle, and apical turns. Box blot diagram of SGC density (number of
SGN/area Rosenthal’s excluding blood vessels). Immediate (PD3 
BDNF) and delayed (PD21  BDNF) neurotrophic treatment results
in significantly higher densities compared with control groups or
contralateral untreated ears. A base–apex gradient of neuronal de-
generation is obvious. SGC density in the basal turn of PD21  BDNF
ears is even higher than in normal hearing animals. Vertical bars
indicate a statistically significant difference between adjacent animal
groups; horizontal bars display no statistically significant difference.
Selected comparisons are beside the graph.
The Journal of Comparative Neurology. DOI 10.1002/cne
1615AFFERENT REGENERATION WITH INTRASCALAR BDNF AND AFGF
14A). Myelin layers are reduced in delayed-NTF-treated
and control animals (PD21; approximately 8–12 layers)
compared with normal (13–22 layers). Myelin sheath of
axons in Rosenthal’s canal appears normal (Fig. 14). SGN
with densely packed neurofilaments, referred to as type II
cells, show high amounts of NMissl bodies in their en-
larged perikarya (Fig. 14B).
DISCUSSION
Our results are consistent with earlier reports showing
a rapid regression of afferent auditory nerve peripheral
processes within days following their deafferentation con-
sequent to loss of IHC. On the other hand, medial and
lateral olivocochlear efferent peripheral processes were
found to be maintained for many weeks following the loss
of their targets, OHC and auditory nerve peripheral pro-
cesses, respectively. Our study is the first to use selective
markers to differentiate the effects of neurotrophic factors
on afferent vs. efferent peripheral processes after deafen-
ing. Our results show the greatest effect on afferents,
providing a significant regrowth of afferent peripheral
processes. The effect on efferent peripheral processes was
more subtle. Chronic BDNF/aFGF did not provide for en-
hanced maintenance of efferents, with the loss of efferent
peripheral processes occurring on a similar time scale in
treated and untreated animals. Treated animals, how-
ever, did have buds of efferent fibers entering into scala
tympani as well as fibers in atypical positions, such as the
inner sulcus (not shown), which was not found in un-
treated animals, suggesting an influence.
Afferents
The kanamycin plus ethacrynic acid deafening condi-
tion produces a rapid loss of IHC and OHC; however, we
do find parvalbumin staining of the few remaining IHC 3
days following this treatment. This may represent IHC
remnants or IHC with delayed cell death. The observation
that no remaining IHC are observed at later periods fol-
lowing deafening is consistent with either explanation.
BDNF/aFGF treatment did not enhance IHC survival,
consistent with the study by Shoji et al. (2000) showing
that, although several other neurotrophic factors en-
hanced IHC survival following noise or ototoxic drugs,
BDNF was not effective. Yamasoba et al. (2001) showed
that FGF was also not effective in protecting hair cells.
BDNF/aFGF treatment did provide a dramatic effect on
afferent processes. Chronic BDNF/aFGF resulted in a sig-
nificantly increased number of afferent peripheral pro-
cesses even after a 3-week delay, comparable to what Wise
et al. (2005) described with BDNF/NT-3 treatment using a
neurofilament stain to identify fibers. Our study used a
specific marker for afferents and provides support for the
idea that most of what Wise et al. described were indeed
afferent processes.
Fig. 11. A–H: Spiral ganglion cell degeneration and NTF treat-
ment. Radial semithin section through the midportion of the modiolus
showing Rosenthal’s canal in the lower basal (1a) turn of normal (A),
deafened (B–F), and neurotrophin-treated (G,H) animals. The spiral
canal is filled with primary neurons sending their peripheral pro-
cesses to the osseous spiral lamina. The intraganglionic spiral bun-
dles containing spirally running efferent nerve fibers are marked with
a star. From PD3 to PD47, SGN number decreases dramatically.
Immediate and delayed NTF administration results in high neuron
density and increased cell size. Scale bars  100 m in A–G; 50 m in
H. [Color figure can be viewed in the online issue, which is available
at www.interscience.wiley.com]
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Fig. 12. Quantitative analysis of spiral ganglion cell diameter. Box
blot chart of SGC diameter (arithmetic mean of longest and shortest
diameter). Whereas deafening results in a decrease in SGN diameter,
neurotrophic treatment provokes an increase in the basal turn, and
delayed NTF treatment leads to increased neuron size throughout all
cochlear turns. Vertical bars indicate a statistically significant differ-
ence between adjacent animal groups; horizontal bars display no
statistically significant difference. Selected comparisons are given
below.
Fig. 13. Neurotrophic effect on spiral ganglion neurons in delayed-
treatment animals (semithin sections of the upper basal turn 1b).
Three weeks postdeafening (A) shows considerable loss of neurons.
Several apoptotic stages of degenerating neurons can be detected
(arrows). Subsequent administration of BDNF and aFGF visualizes
the impressive effect of delayed NTF treatment (B), with large neu-
rons that crowd in Rosenthal’s canal. Scale bars  25 m. [Color
figure can be viewed in the online issue, which is available at www.
interscience.wiley.com]
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Fig. 14. Neurotrophic effect on SGN (electron microscopy). A: Ul-
trastructure gives indication of high cellular metabolism in type I
ganglion neurons with loose chromatin in the nucleus (N) and high
amounts of Nissl bodies (nb) that show normal distribution and no
pathological aggregation within the cell. a, Axon. B: Putative type II
ganglion neuron. The high amount of neurofilaments (nf) leads to an
aggregation of Nissl bodies (nb) that appear more dense than in type
I neurons. Six to ten myelin layers characterize the perikarya of
NTF-treated animals compared with 12–16 layers in normal hearing
animals. Axonal myelinization varies within the same section consid-
erably from loose (A) to very dense (B), comparable to the case in
normal hearing animals. Scale bars  1 m.
Developmental studies show that BDNF and FGF not
only induce the normal connection between auditory neu-
rons and IHC but also act to direct it (Ernfors et al., 1995;
Staecker et al., 1996; Hossain et al., 1997, 2002; Dazert et
al., 1998; Aletsee et al., 2003; Fritzsch et al., 2004). It is
therefore interesting to see the direction and placement of
regrown fibers under our experimental conditions, with
BDNF and aFGF delivered chronically into basal scala
tympani. If BDNF and aFGF act not only to induce re-
growth but also to attract it, one might expect afferent
fiber regrowth into scala tympani. In the current study,
we found many parvalbumin-immunolabeled fibers
sprouting into scala tympani, but these remained in close
proximity to the osseous or membranous spiral lamina
(basilar membrane) and did not traverse through scala
tympani. This is consistent with earlier reports with dif-
ferent NTF combinations (Altschuler et al., 1999; Wise et
al., 2005). Some fibrosis in the scala tympani enhanced
outgrowth of fibers. This suggests that, even with an at-
traction cue, the afferent fibers might still need some
tissue or cellular template to promote growth. It is inter-
esting that in our study outgrowth into the scala tympani
was seen more frequently in the second turn than in the
basal turn. This suggests that a concentration or a con-
centration gradient might play a role in attracting nerve
fibers to sprout into perilymphatic spaces.
Most of the regrowth observed in the current study was
into the remaining tissue above the osseous or membra-
nous spiral lamina. Parvalbumin-immunolabeled afferent
fibers ran toward the location of their former target (IHC)
in the epithelial scar, more medially into the epithelium of
the inner sulcus, and also in distal region toward the outer
sulcus as far as tectal cells. This is comparable to what
was reported by Wise et al. (2005) with BDNF, NT3, and
a neurofilament stain.
In the normal cochlea, peripheral processes lose their
myelin sheath as they exit through the habenula perforata
into the tissue of the organ of Corti to connect with IHC.
The “regrown” fibers that enter scar tissue or remaining
supporting cells above the osseous and membranous spiral
lamina appear to follow the same pattern and are unmy-
elinated after their exit from habenula perforata. On the
other hand, there are satellite cells that show morphology
of typical Schwann cells associated with the outgrowths
that bulge into the scala tympani but no myelin layers. In
the newly formed bulge close to the osseous spiral lamina,
within canaliculi perforantes near Rosenthal’s canal and
fibrous tissue in the scala tympani, nerve fibers are my-
elinated, suggesting the myelinization process is unim-
paired.
Efferents
Efferents are maintained despite their loss of targets.
Whereas McFadden et al. (2004) reported complete loss of
efferents in the basal turn by 21 days following
gentamycin/ethacrynic acid deafening in the chinchilla,
we found excellent survival until 47 days following a com-
parable kanamycin/ethacrynic acid deafening in the
guinea pig model. There was a significant loss in the
medial efferent system, beginning at the site of the outer-
most row of OHC, but no major loss in the inner and
tunnel spiral bundle ascribed to lateral efferents. Al-
though medial efferents are reduced in the scar region of
the basal turn, there are still many myelinated and un-
myelinated fibers in the intraganglionic spiral bundle,
suggesting that medial and lateral efferent fibers, respec-
tively, are still present at this position but may be travel-
ing more toward the apex.
Efferent peripheral processes are not lost immediately
following loss of their target, so it is interesting to consider
what changes might underlie their loss 5–7 weeks later.
One clue could be the base–apex gradient to the timing of
the loss, as previously reported by McFadden et al. (2004).
The loss of efferent processes occurs first in more basal
turns, where the hair cell loss and the progression of scar
formation are more rapid. Scar formation also occurs more
rapidly in the OHC region than more medially. Loss of
efferents might then be associated with the progression of
scar formation and the “flattening” of the scar that occurs
over time with loss of the supporting cells and their re-
placement with squamous epithelium. This goes together
with a more flat scar formation in the basal turn. In
untreated deafened animals, we found the timing of effer-
ent loss to be associated with the latest stage of scar
formation. It may be that the appearance of the late-stage
scar occurs at different rates in different deafness models
(McFadden et al., 2004) and the timing of late-term scar
will coincide with loss of efferents in different deafness
models. On the other hand, this would predict that, if the
formation of a late-term scar is delayed, then efferent loss
would also be delayed. We found that the chronic admin-
istration of BDNF/aFGF slows down the progression of
scar formation, so that at 47 days following deafness there
is only an intermediate-stage scar. Nonetheless, there is
no enhanced maintenance of efferents with the efferent
loss in BDNF/aFGF-treated animals at 47 days following
deafness equivalent to loss in the nontreated deafened
animals.
In deafened untreated animals during the period before
efferent loss, synaptophysin-immunolabeled efferents are
observed in their original positions, despite loss of targets.
It is only in deafened animals receiving BDNF and aFGF
that sprouting of synaptophysin-labeled fibers into the
inner sulcus or under the osseous or membranous spiral
lamina is observed. Despite this sprouting and growth of
efferent fibers, there was no significant increase in their
maintenance, with loss of synaptophysin immunostaining
occurring at comparable times and in comparable
amounts in treated and untreated animals.
Studies by Strominger et al. (1995) showed regeneration
of nerve fibers following an octave-band noise overstimu-
lation perhaps induced by endogenous factors produced by
the remaining normal elements adjacent to the lesion.
This study used acetycholinesterase staining as an effer-
ent marker and concluded that regenerated nerve fibers
were not efferent. This is consistent with our results indi-
cating that the major regrowth induced by neurotrophic
factors is of afferent processes.
Efferent/afferent connections
In the normal cochlea, the lateral olivocochlear efferents
make synaptic contacts with the peripheral processes of
afferents. Under conditions where there is regrowth of
peripheral processes, there is potential for the remaining
lateral efferents to reconnect with the newly appearing
afferent processes. Most of the fixation conditions used in
the present study to allow preembedding immunostaining
are not optimal for synapse identification, and we were not
able to identify synaptic contact between efferents and
afferents. It would be interesting in future studies to in-
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vestigate whether synaptic connections are reformed and,
if not, to develop interventions to promote this reconnec-
tion. The LOC system normally acts to give different set
points to different afferents, increasing the dynamic range
of the auditory nerve. If remaining LOC efferents could be
made to reconnect to regenerated afferents and this con-
nection maintained, perhaps they could reestablish the
increased dynamic range and this could be taken advan-
tage of by cochlear prostheses.
SGN
BDNF/aFGF enhanced the survival of SGN, even after a
3-week delay, consistent with what has been previously
reported with BDNF (Staecker et al., 1996; Miller et al.,
1997; McGuinness and Shepherd, 2005), BDNF/NT-3
(Wise et al., 2005), BDNF/CNTF (Shinohara et al., 2002;
Yamagata et al., 2004), or GDNF (Ylikoski et al., 1998;
Miller et al., 2002). McGuinness and Shepherd (2005)
reported an increase in the size of SGN following BDNF
treatment, and the present study found a similar result
with BDNF/aFGF. There was also an increase in the den-
sity of SGN cells in the profiles through Rosenthal’s canal.
There was no change in the size of the profile of
Rosenthal’s canal and no augmentation of blood vessels
(on the basis of blood vessel area measurements), suggest-
ing there was an increased number of SGN. It is possible
that the increases in cell size influenced the metric for
assessment of density. It is also possible that there is a
movement of SGN, compressing more cells into the same
space, although we did not find decreased densities of
neurons in more apical turns in the delayed-NTF-treated
group. Another possible explanation is that new SGN de-
veloped from endogenous progenitor/stem cells, which
have recently been identified in the human modiolus
(Rask-Andersen et al., 2005) as well as mouse cochlea and
vestibule (Martinez-Monedero et al., 2007; Senn et al.,
2007) under the conditions of deafening, SGN loss, and
BDNF/aFGF treatment.
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